Pharmacological Inhibition of Platelet Reactivity. Clinical and Pharmacodynamic Effects

Publisher： Bentham Science Publishers

E-ISSN： 1875-6212|11|4|431-447

ISSN： 1570-1611

Source： Current Vascular Pharmacology, Vol.11, Iss.4, 2013-07, pp. : 431-447

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Effects of clopidogrel on “aspirin specific” pathways of platelet inhibition

By Hobson Alex   Qureshi Zeshan   Banks Phil   Curzen Nick  

Platelets, Vol. 20, Iss. 6, 2009-09 ,pp. : 386-390

Informa Healthcare

Access to resources Recommend Favorite

Comparison of the pharmacodynamic effects of the platelet ADP receptor antagonists clopidogrel and AR-C69931MX in patients with ischaemic heart disease

By Storey Robert F.   Wilcox Robert G.   Heptinstall Stan  

Platelets, Vol. 13, Iss. 7, 2002-11 ,pp. : 407-413

Informa Healthcare

Access to resources Recommend Favorite

Platelet Glycoprotein IIb / IIIa Inhibition and its Clinical Use

By  

Current Medicinal Chemistry - Cardiovascular & Hematological Agents, Vol. 2, Iss. 3, 2004-07 ,pp. : 187-196

Bentham Science Publishers

Access to resources Recommend Favorite

Beyond platelet inhibition: potential pleiotropic effects of ADP-receptor antagonists

By Iyengar Srinivas   Rabbani LeRoy  

Journal of Thrombosis and Thrombolysis, Vol. 27, Iss. 3, 2009-04 ,pp. : 300-306

Springer Publishing Company

Access to resources Recommend Favorite

Effect of Sarpogrelate, a 5-HT2A Antagonist, on Platelet Aggregation in Patients with Ischemic Stroke: Clinical-Pharmacological Dose-Response Study

By  

Cerebrovascular Diseases, Vol. 24, Iss. 2-3, 2007-07 ,pp. : 264-270

Karger

Access to resources Recommend Favorite